Table 4.
Group | Individuals enrolled (n) | CRC mortality in screening phase | Individuals followed (n) | CRC mortality in follow up phase |
1 | 2538 | 1 (0.04)* | 2525 | 11 (0.42)† |
2 | 1010 | 5 (0.50) | 1004 | 20 (1.99) |
1+2 | 3548 | 6 (0.17) | 3529 | 31 (0.88)‡ |
3 | 1376 | 3 (0.22) | 1369 | 15 (1.10) |
Values are number (%).
*The difference in mortality between the groups during the screening phase was significant (p<0.001).
†Mortality in group 2 was significantly higher than that in groups 1 and 3 (p<0.001 in each case).
‡Mortality in group 1+2 was lower than that in group 3 (p=0.05).